Journal of Cardiovascular Pharmacology

JANUARY 14, 2024

Pretreatment with an oral P2Y12 receptor blocker (before coronary angiography) vs. treatment in the catheterization laboratory has been a matter of debate in patients presenting with non-ST segment elevation myocardial infarction (NSTEMI).

Myocardial Infarction 40

Myocardial Infarction Catheterization Laboratory Laboratory Hypertension 40

Heart BMJ

MAY 10, 2024

Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction. Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction.

Arrhythmia 40

Arrhythmia Myocardial Infarction Atrial Fibrillation Heart Failure 40

Journal of Cardiovascular Pharmacology

SEPTEMBER 5, 2024

An abstract is unavailable. This article is available as a PDF only.

Myocardial Infarction 40

Myocardial Infarction Article 40

Journal of Cardiovascular Pharmacology

JULY 18, 2024

An abstract is unavailable. This article is available as a PDF only.

Myocardial Infarction 40

Myocardial Infarction Article Outcomes 40

Dr. Smith's ECG Blog

FEBRUARY 8, 2015

The supposition that beta blockade in the presence of cocaine intoxication would lead to unopposed alpha constriction is not based in accurate pharmacology, and the study that showed this effect with human intracoronary administration was done, as mentioned in the article, with propranolol, a nonselective beta blocker. de Lemos, J.

Tachycardia 52

Tachycardia Chest Pain Pharmacology Myocardial Infarction 52

Journal of Cardiovascular Pharmacology

APRIL 28, 2024

An abstract is unavailable. This article is available as a PDF only.

Myocardial Infarction 40

Myocardial Infarction Article 40

Journal of Cardiovascular Pharmacology

AUGUST 1, 2024

Thrombosis continues to pose a significant challenge in cardiovascular and cerebrovascular diseases, contributing to severe health complications such as myocardial infarction, acute ischemic stroke, and venous thromboembolism. In this paper, we comment the findings reported by Liu et al.

Cerebrovascular Disease 40

Cerebrovascular Disease Myocardial Infarction Thrombosis Stroke 40

Journal of Cardiovascular Pharmacology

FEBRUARY 4, 2024

An abstract is unavailable. This article is available as a PDF only.

Myocardial Infarction 40

Myocardial Infarction Article 40

Journal of Cardiovascular Pharmacology

APRIL 21, 2024

During a median follow-up of 53 months, we recorded venous thromboembolism (VTE), ischemic stroke or myocardial infarction, along with major bleeding. We observed 4 (6.1%, 3 VTE and 1 ischemic stroke) thrombotic events in patients on apixaban and 12 events (14%, 9 VTE, 2 ischemic strokes and 1 myocardial infarction) in VKA patients.

Myocardial Infarction 40

Myocardial Infarction Thrombosis Stroke Strokes 40

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2024

Patients in the combination AP +AC therapy group had a higher prevalence of CAD, myocardial infarction, and coronary/vascular stent placement compared to the AC monotherapy group. The median follow-up of patients was 57 months. The median follow-up of patients was 57 months.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Kidney Disease Stents 40

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2023

ALDH2 activation reduced ischemic-induced myocardial infarct size and apoptosis. ALDH2 protected mitochondrial function by enhancing mitochondrial RCR and ATP production, alleviated mitochondrial oxidative stress, and suppressed myocardial apoptosis.

Myocardial Infarction 40

Myocardial Infarction Ischemia Article 40

Journal of Cardiovascular Pharmacology

MARCH 5, 2024

Secondary outcomes were the occurrence of thrombotic events, major cardiovascular events, myocardial infarction, and contrast induced nephropathy. Secondary outcomes were the occurrence of thrombotic events, major cardiovascular events, myocardial infarction, and contrast induced nephropathy. 0.92; P=0.02.

Myocardial Infarction 40

Myocardial Infarction Hemorrhage Hospital Outcomes 40

Journal of Cardiovascular Pharmacology

FEBRUARY 11, 2024

Myocardial fibrosis, a common complication of myocardial infarction (MI), is characterized by excessive collagen deposition and can result in impaired cardiac function. The specific role of CD137 in the development of post-MI myocardial fibrosis remains unclear.

Cardiac Function 40

Cardiac Function Myocardial Infarction Article 40

Journal of Cardiovascular Pharmacology

NOVEMBER 6, 2023

Primary endpoint of systematic review and meta-analysis is the NACE (Net Adverse Cardiac Events) and secondary are MACE (Major Adverse Cardiac Events), mortality, bleedings, myocardial infarction and stent thrombosis. Subgroup analyses included studies using only ticagrelor-based regimens and three-months duration of DAPT.

Diabetes 40

Diabetes Myocardial Infarction Thrombosis Stents 40

Dr. Smith's ECG Blog

APRIL 22, 2022

ST-elevation myocardial infarction after pharmacologic persantine stress test in a patient with Wellens’ syndrome. Single High-Sensitivity Cardiac Troponin I to Rule Out Acute Myocardial Infarction. Lancet 2015 6. Patel J, Alattar F, Koneru J, et al. Case Rep Emerg Med 2014 7. Gulati M, Levy P, Mukherjee D, et al.

Chest Pain 52

Chest Pain Ischemia Myocardial Infarction Angina 52

Dr. Smith's ECG Blog

NOVEMBER 19, 2016

myocardial infarction), arrhythmias, valvular pathology, shunts, or outflow obstructions. This patient’s severe aortic stenosis (AS) and associated severe cardiogenic shock likely created the ECG pattern, resulting in a very difficult challenge for our inpatient team.

Ischemia 40

Ischemia Cardiogenic Shock Aortic Stenosis 40

Dr. Paddy Barrett

APRIL 5, 2024

2 Trends and Predictors of Participation in Cardiac Rehabilitation Following Acute Myocardial Infarction: Data From the Behavioral Risk Factor Surveillance System. 7 Secondary prevention following myocardial infarction: a clinical update. 11 Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

Heart Disease 119

Heart Disease Coronary Artery Disease Heart Attack Heart attacks 119

Heart BMJ

JUNE 25, 2024

The 91 villages underwent random allocation into two arms: the control arm, encompassing 45 clusters, was subjected to non-pharmacological intervention (educational training on healthy lifestyle), whereas the intervention arm, comprising 46 clusters, received the non-pharmacological interventions in conjunction with a once-daily polypill tablet.

Cardiovascular Disease 59

Cardiovascular Disease Myocardial Infarction Pharmacology Angina 59

Journal of Cardiovascular Pharmacology

NOVEMBER 11, 2024

Patients with ST-segment elevation myocardial infarction (STEMI) and complex coronary artery disease (CAD) face a poor prognosis, including increased heart failure (HF) risk.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Heart Failure 40

Dr. Smith's ECG Blog

APRIL 8, 2016

Crit Care Med 1991; 19:694) Concentrated Potassium Chloride Infusions in Critically Ill Patients with Hypokalemia The Journal of Clinical Pharmacology. Literature on Hypokalemia as a risk for ventricular fibrillation in acute myocardial infarction. Patients with acute myocardial infarction and a potassium level of less than 4.0

STEMI 52

STEMI Myocardial Infarction Cardiac Arrest Arrhythmia 52

Journal of Cardiovascular Pharmacology

APRIL 9, 2024

However, their effects on acute myocardial infarction (AMI) remain uncertain. However, their effects on acute myocardial infarction (AMI) remain uncertain. Abstract: Recent studies have revealed the benefits of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in heart failure patients.

Myocardial Infarction 40

Myocardial Infarction Diabetes Heart Failure Hospital 40

Journal of Cardiovascular Pharmacology

MAY 23, 2024

In this study, we investigated the safety and efficacy of fondaparinux sodium in post-percutaneous coronary intervention (PCI) anticoagulation therapy for patients with ST-segment elevation myocardial infarction. There are a total of 200 patients with ST segment elevation myocardial infarction underwent PCI and anticoagulation therapy.

Myocardial Infarction 40

Myocardial Infarction STEMI Hospital Article 40

Stroke Journal

JANUARY 30, 2025

This study aimed to identify proteomic expression patterns in large core infarct patients undergoing MT to inform potential pharmacological intervention targets.Methods:The Blood And Clot Thrombectomy Registry And Collaboration (BACTRAC) tissue registry was reviewed for anterior circulation MT patients treated between June 2017-December 2023.

Stroke 40

Stroke Strokes Pharmacology Myocardial Infarction 40

Frontiers in Cardiovascular Medicine

FEBRUARY 27, 2024

Patients with a new or recurrent episode of ASCVD (angina, acute myocardial infarction, transient ischemic attack, stroke, or peripheral arterial disease) between 1-Jan-2017 and 31-Dec-2018 were included. The costs derived from pharmacological treatments were obtained from the NHS pricing nomenclator database ( [link] ).

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Drug Costs Myocardial Infarction 45

Journal of Cardiovascular Pharmacology

NOVEMBER 21, 2023

There were no significant differences in the incidence of other bleeding events, transfusions, stroke, myocardial infarction, or all-cause death. Preoperative non-DAPT significantly reduced minor bleeding events in patients undergoing TAVR, without increasing the risk of stroke and myocardial infarction.

Aortic valve 40

Aortic valve Aortic TAVR Myocardial Infarction 40

DAIC

JANUARY 23, 2024

3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. 4 In the U.S. 12 Importantly, colchicine, 0.5

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Cardiometabolic Health Congress

MAY 10, 2024

Major findings from the INTERHEART study reveal that stress is more common among cases of acute myocardial infarction (AMI) compared to controls. Results revealed that women are twice as likely to exhibit myocardial ischemia in response to mental stress compared to traditional stressors like exercise or pharmacologic stress.

Coronary Artery Disease 59

Coronary Artery Disease Obesity Chest Pain Ischemia 59

Journal of Cardiovascular Pharmacology

MAY 2, 2024

The primary outcome was major adverse cardiac and cerebrovascular event (MACCE), namely a composite of death from cardiovascular causes, myocardial infarction (MI), stroke, stent thrombosis within 12 month. Patient characteristics and clinical outcomes were collected via electronic medical record system.

Outcomes 40

Outcomes Myocardial Infarction Thrombosis Academic 40

Dr. Smith's ECG Blog

NOVEMBER 26, 2018

We discussed several pharmacologic and electrical options. In the best case scenario, all ST segment deviations may cease after a few minutes of normal heart rate, making Occlusion MI less likely. Conversely, if there truly is OMI underlying the rhythm, normalization of the rhythm will expedite its discovery and management.

Ischemia 52

Ischemia Atrial Flutter Arrhythmia Tachycardia 52

Cardiometabolic Health Congress

JULY 25, 2023

17] Glycemic improvement alone, however, has not been associated with improved risk of macrovascular diabetes complications, such as myocardial infarction, stroke and heart failure. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2019.” The Lancet 392.10157 (2018): 1519-1529.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

ObjectivesExercise training is a rehabilitative approach to improve cardiac function in patients with myocardial infarction. However, evidence on the effectiveness of exercise training in these patients remains limited.

Myocardial Infarction 52

Myocardial Infarction Exercise Cardiac Function Pharmacology 52

Frontiers in Cardiovascular Medicine

JANUARY 20, 2025

Despite its known effects on cholesterol metabolism, the role of PCSK9 in cardiac function, especially post-myocardial infarction (MI), remains unclear. Background and aimsProprotein convertase subtilisin/kexin type 9 (PCSK9) plays a crucial role in cholesterol homeostasis by regulating low-density lipoprotein (LDL) receptor levels.

Myocardial Infarction 52

Myocardial Infarction Cardiac Function Cholesterol Pharmacology 52

Dr. Smith's ECG Blog

MARCH 23, 2025

Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? International Evaluation of an Artificial Intelligence-Powered Electrocardiogram Model Detecting Acute Coronary Occlusion Myocardial Infarction.

STEMI 81

STEMI Chest Pain Myocardial Infarction Article 81

Heart BMJ

NOVEMBER 19, 2024

The primary outcome was a composite of all-cause mortality or cardiovascular death and non-fatal myocardial infarction, depending on the definition applied in individual trials, termed as major adverse cardiovascular event (MACE). A common-effect model was used to derive pooled estimates. Secondary outcome was all-cause mortality.

Coronary Artery Disease 52

Coronary Artery Disease Myocardial Infarction Pharmacology Outcomes 52